Caristo Diagnostics
Led multiple digital health companies during last twenty years. Held executive positions with publicly traded companies (GE, Roche, Hillrom, Stereotaxis) and led two venture-backed companies as CEO. Most recently President & CCO of diagnostic company with autonomous AI technology that was FDA-cleared, Medicare-reimbursed, supported by a new Category 1 CPT code, and adopted around the world.
This person is not in any teams
This person is not in any offices
Caristo Diagnostics
Caristo Diagnostics utilises standard CT scans to identify potentially heart-stopping plaques